Reaction
Human Herpesvirus 6 Encephalitis reporting signals
As of the last recalculation, Human Herpesvirus 6 Encephalitis appears in 281 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is AXICABTAGENE CILOLEUCEL (PRR 280.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Axicabtagene Ciloleucel | 33 | 280.5 | 281.5 |
| Fludarabine Phosphate | 97 | 278.5 | 279.2 |
| Thiotepa | 20 | 166.9 | 167.3 |
| Busulfan | 25 | 129.1 | 129.3 |
| Melphalan | 33 | 121.6 | 121.8 |
| Melphalan Hydrochloride | 33 | 110.3 | 110.5 |
| Micafungin Sodium | 12 | 109.5 | 109.6 |
| Ganciclovir | 13 | 98.6 | 98.7 |
| Ganciclovir Sodium | 13 | 95.4 | 95.5 |
| Blinatumomab | 11 | 81.2 | 81.3 |
| Tacrolimus Ointment 0.1% | 92 | 80.9 | 80.9 |
| Tacrolimus Extended-Release Capsules | 92 | 80.7 | 80.7 |
| Tacrolimus | 100 | 72.9 | 72.9 |
| Valganciclovir Hydrochloride Powder, | 10 | 62.9 | 63.0 |
| Basiliximab | 9 | 58.5 | 58.6 |
| Valacyclovir | 26 | 50.8 | 50.8 |